{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:38:18Z","timestamp":1789569498572,"version":"build-2803163510"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.clineuro.2020.105894","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T18:56:19Z","timestamp":1589568979000},"page":"105894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Valproic acid and zonisamide induced hyperammonemic encephalopathy"],"prefix":"10.1016","volume":"196","author":[{"given":"Hristelina S.","family":"Ilieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6996-7725","authenticated-orcid":false,"given":"Joseph W.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald K.","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Croom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2020.105894_bib0005","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra1004418","article-title":"Drug-resistant epilepsy","volume":"365","author":"Kwan","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2020.105894_bib0010","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1528-1157.2000.tb00166.x","article-title":"The cost of epilepsy in the United States: an estimate from population-based clinical and survey data","volume":"41","author":"Begley","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2020.105894_bib0015","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/epi.12125","article-title":"Risk factors for hyperammonemia in pediatric patients with epilepsy","volume":"54","author":"Yamamoto","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2020.105894_bib0020","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/NRL.0b013e3181dba5d3","article-title":"Pharmacology of antiepileptic drugs in clinical practice","volume":"16","author":"Guimaraes","year":"2010","journal-title":"Neurologist"},{"key":"10.1016\/j.clineuro.2020.105894_bib0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/00002018-199005010-00006","article-title":"Acute valproic acid overdose","volume":"5","author":"Dupuis","year":"1990","journal-title":"Drug Saf."},{"key":"10.1016\/j.clineuro.2020.105894_bib0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.seizure.2015.10.015","article-title":"Influence of glutaminase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy","volume":"33","author":"Inoue","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.clineuro.2020.105894_bib0035","first-page":"128","article-title":"Valproic Acid and Topiramate Induced Hyperammonemic Encephalopathy in a patient with normal serum carnitine","volume":"18","author":"Blackford","year":"2013","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.clineuro.2020.105894_bib0040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/MJT.0b013e3182053ef2","article-title":"Thinking beyond the obvious: hepatotoxicity secondary to idiosyncratic depakote toxicity","volume":"19","author":"Chaudrey","year":"2012","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.clineuro.2020.105894_bib0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0404.1985.tb00854.x","article-title":"Valproate: an updated review","volume":"72","author":"Gram","year":"1985","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.clineuro.2020.105894_bib0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/15563659209038632","article-title":"Cerebral edema following acute sodium valproate overdose","volume":"30","author":"Khoo","year":"1992","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.clineuro.2020.105894_bib0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00003088-198510020-00003","article-title":"Concentration-effect relationships of valproic acid","volume":"10","author":"Dhadwick","year":"1985","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.clineuro.2020.105894_bib0060","first-page":"H825","article-title":"Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats","volume":"261","author":"Takahashi","year":"1991","journal-title":"A J Physiol"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720302377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720302377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:36:43Z","timestamp":1759588603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846720302377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":12,"alternative-id":["S0303846720302377"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.105894","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid and zonisamide induced hyperammonemic encephalopathy","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.105894","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105894"}}